Cancer Letters
Volume 208, Issue 2 , Pages 187-191 , 28 May 2004

Extracellular cAMP-dependent protein kinase (ECPKA) in melanoma

  • Tsunekazu Kita

      Affiliations

    • Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, 164 Frelinghuysen Road, Piscataway, NJ 08854, USA
    • Department of Obstetrics and Gynecology, National Defense Medical College, Tokorozawa, Saitama, Japan
    • ,
  • James Goydos

      Affiliations

    • Department of Surgery, School of Public Health; Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA
    • ,
  • Elena Reitman

      Affiliations

    • Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, 164 Frelinghuysen Road, Piscataway, NJ 08854, USA
    • ,
  • Roald Ravatn

      Affiliations

    • Informax, Frederick, MD, USA
    • ,
  • Yong Lin

      Affiliations

    • Division of Biometrics, School of Public Health; Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA
    • ,
  • Wei-Chung Shih

      Affiliations

    • Division of Biometrics, School of Public Health; Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA
    • ,
  • Yoshihiro Kikuchi

      Affiliations

    • Department of Obstetrics and Gynecology, National Defense Medical College, Tokorozawa, Saitama, Japan
    • ,
  • Khew-Voon Chin

      Affiliations

    • Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, 164 Frelinghuysen Road, Piscataway, NJ 08854, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-732-445-3400x253; fax: +1-732-445-0687

Received 17 October 2003 ,Revised 18 February 2004 ,Accepted 19 February 2004.

References 

  1. Bataille V. Genetic epidemiology of melanoma. Eur. J. Cancer. 2003;39:1341–1347
  2. Meier F, Satyamoorthy K, Nesbit M, Hsu MY, Schittek B, Garbe C, et al. Molecular events in melanoma development and progression. Front Biosci. 1998;3:D1005–D1010
  3. Satyamoorthy K, Herlyn M. Cellular and molecular biology of human melanoma. Cancer Biol. Ther. 2002;1:14–17
  4. Chin KV, Yang WL, Ravatn R, Kita T, Reitman E, Vettori D, et al.  Reinventing the wheel of cyclic AMP: novel mechanisms of cAMP signaling. Ann. NY Acad. Sci. 2002;968:49–64
  5. Kopperud R, Krakstad C, Selheim F, Doskeland SO. cAMP effector mechanisms. Novel twists for an old signaling system. Fed. Eur. Biochem. Sci. Lett. 2003;546:121–126
  6. Cho YS, Park YG, Lee YN, Kim MK, Bates S, Tan L, et al.  Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression. Proc. Natl. Acad. Sci. USA. 2000;97:835–840
  7. Cho YS, Lee YN, Cho-Chung YS. Biochemical characterization of extracellular cAMP-dependent protein kinase as a tumor marker. Biochem. Biophys. Res. Commun. 2000;278:679–684
  8. Cvijic ME, Kita T, Shih W, DiPaola RS, Chin KV. Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer. Clin. Cancer Res. 2000;6:2309–2317
  9. Maller JL, Kemp BE, Krebs EG. In vivo phosphorylation of a synthetic peptide substrate of cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA. 1978;75:248–251
  10. Whitehouse S, Walsh DA. Mg X ATP2-dependent interaction of the inhibitor protein of the cAMP-dependent protein kinase with the catalytic subunit. J. Biol. Chem. 1983;258:3682–3692
  11. Celis JE, Gromov P. Proteomics in translational cancer research: toward an integrated approach. Cancer Cell. 2003;3:9–15
  12. Srinivas PR, Verma M, Zhao Y, Srivastava S. Proteomics for cancer biomarker discovery. Clin. Chem. 2002;48:1160–1169
  13. Negm RS, Verma M, Srivastava S. The promise of biomarkers in cancer screening and detection. Trends Mol. Med. 2002;8:288–293
  14. Frank R, Hargreaves R. Clinical biomarkers in drug discovery and development. Nat. Rev. Drug. Discov. 2003;2:566–580

PII: S0304-3835(04)00171-5

doi: 10.1016/j.canlet.2004.02.018

Cancer Letters
Volume 208, Issue 2 , Pages 187-191 , 28 May 2004

Article Tools

* Image Usage & Resolution